Form 8-K - Current report:
SEC Accession No. 0001558370-25-007752
Filing Date
2025-05-14
Accepted
2025-05-14 16:13:33
Documents
16
Period of Report
2025-05-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K armp-20250514x8k.htm   iXBRL 8-K 37305
2 EX-99.1 armp-20250514xex99d1.htm EX-99.1 181549
3 GRAPHIC armp-20250514xex99d1001.jpg GRAPHIC 3047
  Complete submission text file 0001558370-25-007752.txt   362527

Data Files

Seq Description Document Type Size
4 EX-101.SCH armp-20250514.xsd EX-101.SCH 4118
5 EX-101.DEF armp-20250514_def.xml EX-101.DEF 2859
6 EX-101.LAB armp-20250514_lab.xml EX-101.LAB 16594
7 EX-101.PRE armp-20250514_pre.xml EX-101.PRE 10918
18 EXTRACTED XBRL INSTANCE DOCUMENT armp-20250514x8k_htm.xml XML 4656
Mailing Address 5005 MCCONNELL AVE LOS ANGELES CA 90066
Business Address 5005 MCCONNELL AVE LOS ANGELES CA 90066 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37544 | Film No.: 25945651
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)